Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China · Delayed Price · Currency is CNY 9.30
-0.15 (-1.59%)
Sep 10, 2026, 1:15 PM CST
SHE:002728 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 826.71 | 924.53 | 687.79 | 1,067 | 886.57 | 758.16 |
Revenue Growth | -4.45% | 34.42% | -35.55% | 20.38% | 16.94% | 19.83% |
Gross Profit Gross Profit Growth | 431.44 | 503.36 | 301.32 | 599.23 | 434.74 | 402.04 |
Operating Income Operating Income Growth | 74.04 | 80.82 | 30.43 | 306.04 | 217.99 | 177.33 |
Net Income Net Income Growth | 74.77 | 81.67 | 20.5 | 253.18 | 178.2 | 126.92 |
Earnings Per Share EPS Growth | 0.14 | 0.16 | 0.04 | 0.55 | 0.41 | 0.32 |
EPS Growth | 21.09% | 300.00% | -92.73% | 35.10% | 28.71% | 181.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 811.12 | 908.06 | 671.61 | 1,051 |
Pharmaceutical Business Pharmaceutical Business Growth | 8.78 | 9.46 | 9.46 | 10.74 |
Chemical Products and Others Chemical Products and Others Growth | 6.81 | 7.01 | 6.71 | 5.84 |
Total Total Growth | 826.71 | 924.53 | 687.79 | 1,067 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 556.32 | 336.15 | 457.41 | 647.25 | 739.66 | 372.47 |
Total Debt Total Debt Growth | 424.2 | 263.54 | 516.09 | 306 | 847.18 | 662.18 |
Net Cash (Debt) Net Cash Growth | 132.12 | 72.61 | -58.68 | 341.25 | -107.52 | -289.71 |
Net Cash Growth | 157.75% | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.25 | 0.14 | -0.11 | 0.74 | -0.25 | -0.72 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 183.27 | 244.09 | -22.55 | 198.56 | 371.66 | 256.81 |
Capital Expenditures CapEx Growth | -73.37 | -79.55 | -113.56 | -86.05 | -90.26 | -109.58 |
Free Cash Flow Free Cash Flow Growth | 109.91 | 164.54 | -136.11 | 112.51 | 281.39 | 147.24 |
Free Cash Flow Growth | 40.94% | - | - | -60.02% | 91.11% | 85.05% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 52.19% | 54.45% | 43.81% | 56.15% | 49.04% | 53.03% |
Operating Margin | 8.96% | 8.74% | 4.42% | 28.68% | 24.59% | 23.39% |
Pretax Margin | 9.26% | 8.90% | 3.21% | 27.45% | 22.14% | 19.40% |
Profit Margin | 9.04% | 8.83% | 2.98% | 23.72% | 20.10% | 16.74% |
FCF Margin | 13.29% | 17.80% | -19.79% | 10.54% | 31.74% | 19.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.050 | 0.357 | 0.332 | 0.332 |
Dividend Per Share Growth | 200.00% | 200.00% | -86.00% | 7.69% | 0% | 0% |
Dividend Yield | 1.67% | 1.41% | 0.57% | 2.96% | 3.14% | 4.34% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 67.25 | 66.33 | 217.47 | 25.72 | 28.05 | 29.90 |
Forward PE | - | 26.46 | 14.16 | - | - | - |
P/FCF Ratio | 43.92 | 32.92 | - | 57.87 | 17.76 | 25.77 |
PS Ratio | 5.84 | 5.86 | 6.48 | 6.10 | 5.64 | 5.01 |